Even as chemoprevention is emerging as a realistic and a sensible modality for cancer control, knowledge on the molecular biomarkers and genetic signatures involved in the process of carcinogenesis will further allow customized targeted development of chemopreventive regimens for individualized
No takes yet. Share an insight, caveat, or question.
Adhami et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: